Drug
Imlifidase
Imlifidase: highest development phase Phase 2, developed by Hansa Biopharma AB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hansa Biopharma AB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Imlifidase NCT05753930 | Phase 2 | Kidney Transplantation in Highly Sensitized Patients |
Latest
No recent events.
Follow Imlifidase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.